Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/8365
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorCoutinho, Elsimar Metzker-
dc.contributor.authorMelo, José F.-
dc.creatorCoutinho, Elsimar Metzker-
dc.creatorMelo, José F.-
dc.date.accessioned2013-02-04T19:30:22Z-
dc.date.available2013-02-04T19:30:22Z-
dc.date.issued1988-
dc.identifier.issn0010-7824-
dc.identifier.urihttp://www.repositorio.ufba.br/ri/handle/ri/8365-
dc.descriptionTexto completo. Acesso restrito. p. 137–151pt_BR
dc.description.abstractGossypol monoacetic acid was administered to 12 Brazilian volunteers. The initial dose was 20 mg daily for 4 months. The dose was then reduced to 60 mg weekly (20 mg three times weekly). A significant reduction in sperm motility was detected in all subjects. An increase in the number of immature cells in the ejaculate was also detected in all subjects. Severe oligospermia or azoospermia developed in all subjects at the end of the loading phase. Two years following discontinuation, 3 men were still azoospermic. Only 1 man who was azoospermic 2 years after discontinuation had a late (3 years) recovery. Two of the 3 men who were subjected to high spermatic vein ligation because of varicocele remained azoospermic 2 years after the operation. The third patient, who did not have the operation, also remained azoospermic. Of the 9 patients who recovered, 3 have fathered children during the last 2 years.pt_BR
dc.language.isoenpt_BR
dc.publisherContraceptionpt_BR
dc.sourcehttp://dx.doi.org/10.1016/0010-7824(88)90124-2pt_BR
dc.titleClinical experience with gossypol in non-chinese men: a follow-uppt_BR
dc.title.alternativeContraceptionpt_BR
dc.typeArtigo de Periódicopt_BR
dc.description.localpubSalvadorpt_BR
dc.identifier.numberv. 37, n. 2pt_BR
Aparece nas coleções:Artigo Publicado em Periódico Estrangeiro (ISC)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
6666666666.pdf1,6 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.